Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells 12,496,077 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $143,704,885.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Friday, August 21st, J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock. The stock was sold at an average price of $11.50, for a total transaction of $25,875,000.00.
• On Tuesday, June 30th, J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.01, for a total value of $19,376,470.35.
• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.00, for a total transaction of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total value of $36,455,577.60.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH traded up $0.54 during trading on Monday, reaching $13.70. 5,371,630 shares of the company traded hands, compared to its average volume of 1,804,159. Aveanna Healthcare Holdings Inc. has a 52 week low of $5.93 and a 52 week high of $13.98. The company’s 50 day moving average is $9.58 and its two-hundred day moving average is $7.92. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The firm has a market capitalization of $2.99 billion, a PE ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. As a group, sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
• Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
• Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing

Analyst Upgrades and Downgrades

AVAH has been the subject of a number of research analyst reports. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Raymond James Financial raised their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday, August 14th. BMO Capital Markets lifted their price objective on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, UBS Group upped their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $12.89.

Hedge Funds Weigh In On Aveanna Healthcare

Large investors have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd grew its stake in shares of Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares in the last quarter. C M Bidwell & Associates Ltd. bought a new position in shares of Aveanna Healthcare during the second quarter valued at about $69,000. Summit Securities Group LLC purchased a new position in Aveanna Healthcare during the first quarter worth about $53,000. Quantbot Technologies LP bought a new stake in Aveanna Healthcare in the 2nd quarter worth about $43,000. Finally, Freestone Grove Partners LP bought a new stake in Aveanna Healthcare in the 2nd quarter worth about $73,000. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.